These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 26090645)

  • 1. Autosomal dominant polycystic kidney disease: the changing face of clinical management.
    Ong AC; Devuyst O; Knebelmann B; Walz G;
    Lancet; 2015 May; 385(9981):1993-2002. PubMed ID: 26090645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in autosomal dominant polycystic kidney disease-2014 and beyond.
    Braun WE
    Cleve Clin J Med; 2014 Sep; 81(9):545-56. PubMed ID: 25183846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.
    Saigusa T; Bell PD
    Physiology (Bethesda); 2015 May; 30(3):195-207. PubMed ID: 25933820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease.
    Rangan GK; Alexander SI; Campbell KL; Dexter MA; Lee VW; Lopez-Vargas P; Mai J; Mallett A; Patel C; Patel M; Tchan MC; Tong A; Tunnicliffe DJ; Vladica P; Savige J
    Nephrology (Carlton); 2016 Aug; 21(8):705-16. PubMed ID: 26511892
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of autosomal dominant polycystic kidney disease].
    Torra R
    Med Clin (Barc); 2014 Jan; 142(2):73-9. PubMed ID: 24246705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Slow the pace of renal failure in autosomal dominant polycystic kidney disease: hopes and disappointments].
    Burtey S
    Presse Med; 2011 Nov; 40(11):1059-64. PubMed ID: 21964037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease].
    Joly D
    Med Sci (Paris); 2011 Mar; 27(3):249-51. PubMed ID: 21447293
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recent advances in studies on autosomal dominant adult polycystic kidney disease].
    Yu CW; Zhang SZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Aug; 27(4):402-5. PubMed ID: 20677145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic analysis (PKD2) of autosomal dominant polycystic kidney disease].
    Gómez PF; Moro EC; García-Cosmes P; Sarmiento RG; Romo JM
    Nefrologia; 2009; 29(6):562-8. PubMed ID: 19936001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany.
    Neumann HP; Jilg C; Bacher J; Nabulsi Z; Malinoc A; Hummel B; Hoffmann MM; Ortiz-Bruechle N; Glasker S; Pisarski P; Neeff H; Krämer-Guth A; Cybulla M; Hornberger M; Wilpert J; Funk L; Baumert J; Paatz D; Baumann D; Lahl M; Felten H; Hausberg M; Zerres K; Eng C;
    Nephrol Dial Transplant; 2013 Jun; 28(6):1472-87. PubMed ID: 23300259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease (ADPKD).
    Hoefele J; Mayer K; Scholz M; Klein HG
    Nephrol Dial Transplant; 2011 Jul; 26(7):2181-8. PubMed ID: 21115670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal dominant polycystic kidney disease and mTOR inhibitors: the narrow road between hope and disappointment.
    Ponticelli C; Locatelli F
    Nephrol Dial Transplant; 2010 Dec; 25(12):3809-12. PubMed ID: 20798121
    [No Abstract]   [Full Text] [Related]  

  • 13. Practical genetics for autosomal dominant polycystic kidney disease.
    Pei Y
    Nephron Clin Pract; 2011; 118(1):c19-30. PubMed ID: 21071968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene diagnosis of autosomal dominant polycystic kidney disease type 2 using microsatellite DNA tightly linked to polycystic kidney disease gene 2].
    Zhang WL; Zhang DY; Wu YM; Sun TM; Mei CL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):325-8. PubMed ID: 15300626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
    Cai Y; Tang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Genetic Testing for Diagnosis.
    Tchan M; Savige J; Patel C; Mallett A; Tong A; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):545-549.e2. PubMed ID: 26718157
    [No Abstract]   [Full Text] [Related]  

  • 17. mTOR signaling in polycystic kidney disease.
    Ibraghimov-Beskrovnaya O; Natoli TA
    Trends Mol Med; 2011 Nov; 17(11):625-33. PubMed ID: 21775207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation of the PKD2 gene in a Japanese patient with autosomal dominant polycystic kidney disease and complete situs inversus.
    Oka M; Mochizuki T; Kobayashi S
    Am J Kidney Dis; 2014 Oct; 64(4):660. PubMed ID: 25149526
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molecular genetic diagnosis of autosomal dominant polycystic kidney disease].
    Reiterová J; Merta M; Stekrová J; Tesar V
    Sb Lek; 2002; 103(4):435-42. PubMed ID: 12688156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnosis of autosomal dominant polycystic kidney disease.
    Torra Balcells R; Ars Criach E
    Nefrologia; 2011; 31(1):35-43. PubMed ID: 21270911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.